Navigation Links
Adeona's Multiple Sclerosis Trial Receives $409,426 Grant
Date:3/28/2011

ANN ARBOR, Mich., March 28, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that the ongoing clinical trial of its Trimesta™ (oral estriol) drug candidate has received an additional $409,426 in grant funding from the National Multiple Sclerosis Society (NMSS). The clinical trial is led by, Rhonda Voskuhl, M.D., Director, University of California Los Angeles (UCLA) Multiple Sclerosis Program, UCLA Department of Neurology. Adeona also announced that as of March 1, 2011, the clinical trial evaluating the reduction in the rate of relapses in female multiple sclerosis (MS) patients is 85% enrolled.

"We are very grateful to the NMSS for its continuous support of this MS program, from the preclinical development to the pilot and multi-center clinical trials, and now this current grant funding," said Dr. Voskuhl. "Their commitment to pursuing estriol for MS could potentially lead to a new, safe and effective oral therapy for this debilitating disease."

This ongoing clinical trial previously received a $5 million grant from the NMSS in partnership with the NMSS's Southern California chapter, with support from the National Institutes of Health, and $860,440 in grant funding through the American Recovery and Reinvestment Act. In November 2010, Adeona announced that it was awarded $244,480 under the Qualifying Therapeutic Discovery Project Program to support research and development expenses related to the Company's MS program.

The 150-patient, randomized, double-blind, placebo-controlled clinical trial of Trimesta is currently underway at 15 centers in the United States. Investigators are administering either Trimesta or matching placebo along with glatimer acetate (Copaxone®), an FDA-approved therapy for MS, to women between the ages of 18-50 who have
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... HILLS, Calif. , May 24, 2013 /PRNewswire-iReach/ -- ... state,s leading non-profit substance abuse services organization, is hosting ... the Beverly Hills Hotel on June 6, 2013.  More ... to raise funds for the adolescent residential treatment centers, ... well as honor individuals whose accomplishments have positive influences ...
(Date:5/24/2013)... -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today ... Bank Health Care Conference to be held May 29-30 ... Adrian Adams , Chief Executive Officer and President, ... and its product pipeline at 12:00 p.m. ET on ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also be ...
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
Breaking Medicine Technology:Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 2Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 43SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... 1 Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: ... University to be presented by Howard Safran, M.D., head ... oral session at the Annual Meeting of the International ... with cancer of the lower esophagus demonstrated a high ...
... Baxa Corporation announces the launch of a new ... Pharmacy Workflow Manager products. The Baxa IntelliSource(TM) program ... they need to ensure that each dose dispensed is ... one-time setup fees or signing capital leases. , "Our ...
Cached Medicine Technology:OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 2OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 3OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 4OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer 5Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R) 2Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R) 3
(Date:5/24/2013)... 24, 2013 Range Kleen Mfg. strives to ... the Customer, from the President's desk to the Shipping Dock.” ... and integrity, and having passion while creating excellence and quality ... a company to do the right thing and what better ... those affected by devastation. , Throughout the year Range Kleen ...
(Date:5/24/2013)... Alan Mozes HealthDay Reporter , , FRIDAY, May ... Lewis, accomplishments are remarkable. But it was a physical ... the top of her sport. "I was an ... when my scoliosis was diagnosed by my orthopedic surgeon," ... the Scoliosis Research Society and the American Academy of ...
(Date:5/24/2013)... 24, 2013 With Memorial Day Weekend upon ... Insurance is offering tips to help prevent grill fires ... Protection Association (NFPA) reports that gas grills led to ... Charcoal or other solid-fueled grills, meanwhile, caused approximately 1,200 home ... result, Amica Insurance is sharing the following tips from the ...
(Date:5/24/2013)... OR (PRWEB) May 24, 2013 ... Sustainable Cards, major competitors in sustainable card material, ... of using forest materials as a sustainable gift ... is to identify industry challenges and increase education ... card programs to support the reduction of carbon ...
(Date:5/24/2013)... Area homeowners dreaming about owning a hot tub will ... from at factory-direct pricing during the Jacuzzi Hot Tubs ... at Emerald Pool and Patio in Bend, May ... leading hot tub brand, scheduled the event as part of ... feature popular hot tub models at up to 50% savings ...
Breaking Medicine News(10 mins):Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2
... Hospitals with more expertise handling these attacks also ... News) -- Brain hemorrhage patients have better outcomes ... handle many brain attack emergencies, according to updated ... Subarachnoid hemorrhage (SAH) occurs when a blood vessel ...
... RMD ), announced today that on Thursday, February 5, 2009, it ... 2009, ended December 31, 2008. ResMed will issue an earnings press ... call to review its quarterly results, market trends, and future outlook. ... begin at 1:30 p.m. Pacific Time and will be webcast on ...
... Jan. 22 This is a sad day for the ... should be led from the bottom up, rather than the ... decision are predictable. It also is predictable that Hearing ... by SEIU President Andy Stern to conduct the hearing would ...
... ST. PAUL, Minn., Jan. 22 Project 515 is proposing,legislation to ... severe health issues and the death of a loved one. , ... Capitol news conference,today, will provide committed same-sex couples the same right ... final wishes of their partners, -- Preserve their ...
... patients, families , , THURSDAY, Jan. 22 (HealthDay News) -- ... discussion when physicians talk to patients about serious medical ... The study, published in the January issue of ... , said nurses play a critical role with the ...
... maxim "location, location, location" also plays a role in ... behavior of other people. , University of Washington psychologists ... and understanding of familiar actions by a person to ... by the location in which the new action is ...
Cached Medicine News:Health News:New Brain Hemorrhage Guidelines Stress Quick Action 2Health News:ResMed to Webcast Second Quarter 2009 Earnings Conference Call 2Health News:Statement by UHW on SEIU's Claims Regarding SEIU-Trusteeship Hearing Process Chaired by Ray Marshall 2Health News:Project 515 Proposes Legislation to Ensure Equality During Times of Illness and Death 2Health News:Project 515 Proposes Legislation to Ensure Equality During Times of Illness and Death 3Health News:Nurses Often Left Out of Medical Error Talks 2Health News:Infants draw on past to interpret present, understand other people's behavior 2Health News:Infants draw on past to interpret present, understand other people's behavior 3
Stryker Instruments, the leader in surgical helmets, offers its 4th generation of personal protection systems for todays surgical environment the Sterishield T4 System....
... The PS Medical Delta valve is ... fluid (CSF) and maintain intraventricular pressure ... regardless of patient position. The normally ... response to positive ventricular pressure. Working ...
... PS Medical Strata valve is an adjustable ... properties of the valve can be changed ... to minimize overdrainage of cerebrospinal fluid (CSF) ... normal physiologic range, regardless of patient position. ...
...
Medicine Products: